Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, a Novel 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects

by Susan Bellaire, Mark Walzer, Tianli Wang, Walter Krauwinkel, Nancy Yuan, Gerard J. Marek
Published 2019-05-01

Response to ‘Modeling is data driven: Use it for successful virtual patient generation’

by Stephen B. Duffull, Abhishek Gulati
Published 2021-05-01

Potential Issues With Virtual Populations When Applied to Nonlinear Quantitative Systems Pharmacology Models

by Stephen Duffull, Abhishek Gulati
Published 2020-11-01

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of a Drug–Drug Interaction of Combined Effects on P‐glycoprotein and Cytochrome P450 3A

by Yukio Otsuka, Mary P. Choules, Peter L. Bonate, Kanji Komatsu
Published 2020-11-01

The Prospective Antifungal Therapy Alliance® Registry: A Two-Centre Canadian Experience

by Shariq Haider, Coleman Rotstein, David Horn, Michel Laverdiere, Nkechi Azie
Published 2014-01-01

Chemical Stability of Telavancin in Elastomeric Pumps

by Patrick Sand, MSc, Traci Aladeen, BA, Paul Kirkegaard, BS, Dennis LaChance, BS, Christine Slover, PharmD
Published 2015-12-01

Collaborations between Clinical Pharmacologists in Japan and in the United States ‐ Report from the IQ CPLG and JPMA CPTF Meeting in Tokyo, Japan

by Tong Zhu, Makoto Kayama, Sandhya Girish, Vikram Sinha, Akintunde Bello, Atsuhiro Kawaguchi, Richard Czerniak, Lee Nagao
Published 2021-01-01

Experimental and Analytical Collapse Evaluation of an Existing Building

by Akah, Ebiji Anthony
Published 2015

Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer

by Hiroyuki Sayama, Diana Marcantonio, Takeyuki Nagashima, Masashi Shimazaki, Tsuyoshi Minematsu, Joshua F Apgar, John M. Burke, Lucia Wille, Yasuhisa Nagasaka, Daniel C. Kirouac
Published 2021-08-01

Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor

by Varun Garg, Jinshan Shen, Chonghua Li, Sagar Agarwal, Asfiha Gebre, Sarah Robertson, Jiayin Huang, Linda Han, Licong Jiang, Kristin Stephan, Linda T. Wang, Julie Lekstrom‐Himes
Published 2019-05-01

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer

by Hideki Maeda, Kentaro Takeda, Hisashi Urushihara, Tatsuo Kurokawa
Published 2021-06-01

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins

by Andrzej M. Kierzek, Timothy P. Hickling, Isabel Figueroa, J. Cory Kalvass, Marjoleen Nijsen, Krithika Mohan, Geertruida M. Veldman, Akihiro Yamada, Hiroyuki Sayama, Sachiko Yokoo, Abhishek Gulati, Renu S. Dhanikula, Jochem Gokemeijer, Tarek A. Leil, Craig J. Thalhauser, Mario Giorgi, Maciej J. Swat, Vijayalakshmi Chelliah, Ben G. Small, Neil Benson, Michael Walker, Kapil Gadkar, Valerie Quarmby, Rong Deng, Andrea Ferrante, Gemma L. Dickinson, Jan‐Stefan Van Der Walt, Lian Zhou, Xiaoying Chen, Hannah M. Jones, Jatin Narula, Sophie Tourdot, Thierry Lavé, Benjamin Ribba, Piet H. van derGraaf
Published 2019-11-01

EXPERIMENTAL AND ANALYTICAL ASSESSMENT ON THE PROGRESSIVE COLLAPSE POTENTIAL OF EXISTING BUILDINGS

by Song, Brian Inhyok
Published 2010